Lista de obras - Serena Guiducci - Dominio Público Uruguay

2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative

artículo científico publicado en 2013

A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis

artículo científico publicado en 2011

A loss of telocytes accompanies fibrosis of multiple organs in systemic sclerosis

artículo científico

A model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients

artículo científico publicado en 2006

Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis

artículo científico publicado en 2017

Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers

artículo científico publicado en 2002

Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synovium

artículo científico publicado en 2017

Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro

artículo científico publicado en 2011

Bosentan blocks the antiangiogenic effects of sera from systemic sclerosis patients: an in vitro study

artículo científico publicado en 2015

Calcinosis in systemic sclerosis: subsets, distribution and complications

artículo científico publicado en 2016

Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis

artículo científico publicado en 2015

Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesis

artículo científico publicado en 2013

Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications

artículo científico publicado en 2006

Digital ulcers as a sentinel sign for early internal organ involvement in very early systemic sclerosis

artículo científico publicado en 2014

Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions

artículo científico publicado en 2010

Distinct expression of adhesion molecules on skin fibroblasts from patients with diffuse and limited systemic sclerosis. A pilot study

artículo científico publicado en 2005

EUSTAR biobanking: recommendations for the collection, storage and distribution of biospecimens in scleroderma research

artículo científico publicado en 2011

Early detection of myocardial and pulmonary oedema with MRI in an asymptomatic systemic sclerosis patient: successful recovery with pulse steroid

artículo científico publicado en 2013

Elevated serum levels of sonic hedgehog are associated with fibrotic and vascular manifestations in systemic sclerosis.

artículo científico publicado en 2017

Evidence for caveolin-1 as a new susceptibility gene regulating tissue fibrosis in systemic sclerosis

artículo científico publicado en 2012

Evidence for progressive reduction and loss of telocytes in the dermal cellular network of systemic sclerosis

artículo científico publicado en 2013

Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group.

artículo científico publicado en 2017

High frequency ultrasound measurement of digital dermal thickness in systemic sclerosis

artículo científico publicado en 2009

High serum sCD163/sTWEAK ratio is associated with lower risk of digital ulcers but more severe skin disease in patients with systemic sclerosis

artículo científico publicado en 2013

Hydroxychloroquine and joint involvement in systemic sclerosis: Preliminary beneficial results from a retrospective case-control series of an EUSTAR center

artículo científico publicado en 2016

Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005

artículo científico publicado en 2007

Immunosuppression for interstitial lung disease in systemic sclerosis

artículo científico

Impaired angiogenesis in systemic sclerosis: the emerging role of the antiangiogenic VEGF(165)b splice variant

artículo científico

Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma?

artículo científico publicado en 2013

Increased plasma levels of the VEGF165b splice variant are associated with the severity of nailfold capillary loss in systemic sclerosis

artículo científico publicado en 2013

Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage

artículo científico publicado en 2012

International consensus criteria for the diagnosis of Raynaud's phenomenon

artículo científico publicado en 2014

Interstitial lung disease in systemic sclerosis: where do we stand?

artículo científico publicado en 2015

Is immunosuppressive therapy the anchor treatment to achieve remission in systemic sclerosis?

artículo científico

Lack of efficacy of quinapril on vascular damage in limited cutaneous systemic sclerosis

artículo científico publicado en 2008

Lung ultrasound for the screening of interstitial lung disease in very early systemic sclerosis

artículo científico publicado en 2012

Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis

artículo científico publicado en 2010

Musculoskeletal involvement in systemic sclerosis

artículo científico publicado en 2008

One year in review 2016: spondyloarthritis

artículo científico publicado en 2017

Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis

artículo científico publicado en 2015

Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis

artículo científico publicado en 2013

Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells

artículo científico publicado en 2017

Progressive loss of lymphatic vessels in skin of patients with systemic sclerosis

artículo científico publicado en 2010

RANK-RANKL-OPG in hemophilic arthropathy: from clinical and imaging diagnosis to histopathology

artículo científico publicado en 2012

Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy

artículo científico publicado en 2011

Reduced circulating levels of angiotensin-(1--7) in systemic sclerosis: a new pathway in the dysregulation of endothelial-dependent vascular tone control

artículo científico publicado en 2007

Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis

artículo científico publicado en 2017

Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide

artículo científico publicado en 2015

Systemic sclerosis and infections

scientific article published on 13 August 2008

Systemic sclerosis sera affect fibrillin-1 deposition by dermal blood microvascular endothelial cells: therapeutic implications of cyclophosphamide

scientific article published on 20 August 2013

Systemic sclerosis: a critical digest of the recent literature

artículo científico

Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis

artículo científico publicado en 2015

The "myth" of loss of angiogenesis in systemic sclerosis: a pivotal early pathogenetic process or just a late unavoidable event?

artículo científico publicado en 2017

The antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosis

artículo científico publicado en 2005

The crowded crossroad to angiogenesis in systemic sclerosis: where is the key to the problem?

artículo científico publicado en 2016

The role of infections in the immunopathogensis of systemic sclerosis--evidence from serological studies

artículo científico publicado en 2009

Update of EULAR recommendations for the treatment of systemic sclerosis

artículo científico publicado en 2016

Upregulation of the N-formyl Peptide receptors in scleroderma fibroblasts fosters the switch to myofibroblasts

artículo científico publicado en 2015

Vascular biomarkers and correlation with peripheral vasculopathy in systemic sclerosis

artículo científico publicado en 2014

Vascular complications of scleroderma

artículo científico publicado en 2007

Vascular injury in systemic sclerosis: angiotensin-converting enzyme insertion/deletion polymorphism

artículo científico publicado en 2004

Very early versus early disease: the evolving definition of the 'many faces' of systemic sclerosis

artículo científico publicado en 2012

Lista de obras de Serena Guiducci

2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative

A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis

A loss of telocytes accompanies fibrosis of multiple organs in systemic sclerosis

A model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients

Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis

Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers

Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synovium

Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro

Bosentan blocks the antiangiogenic effects of sera from systemic sclerosis patients: an in vitro study

Calcinosis in systemic sclerosis: subsets, distribution and complications

Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis

Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesis

Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications

Digital ulcers as a sentinel sign for early internal organ involvement in very early systemic sclerosis

Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions

Distinct expression of adhesion molecules on skin fibroblasts from patients with diffuse and limited systemic sclerosis. A pilot study

EUSTAR biobanking: recommendations for the collection, storage and distribution of biospecimens in scleroderma research

Early detection of myocardial and pulmonary oedema with MRI in an asymptomatic systemic sclerosis patient: successful recovery with pulse steroid

Elevated serum levels of sonic hedgehog are associated with fibrotic and vascular manifestations in systemic sclerosis.

Evidence for caveolin-1 as a new susceptibility gene regulating tissue fibrosis in systemic sclerosis

Evidence for progressive reduction and loss of telocytes in the dermal cellular network of systemic sclerosis

Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group.

High frequency ultrasound measurement of digital dermal thickness in systemic sclerosis

High serum sCD163/sTWEAK ratio is associated with lower risk of digital ulcers but more severe skin disease in patients with systemic sclerosis

Hydroxychloroquine and joint involvement in systemic sclerosis: Preliminary beneficial results from a retrospective case-control series of an EUSTAR center

Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005

Immunosuppression for interstitial lung disease in systemic sclerosis

Impaired angiogenesis in systemic sclerosis: the emerging role of the antiangiogenic VEGF(165)b splice variant

Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma?

Increased plasma levels of the VEGF165b splice variant are associated with the severity of nailfold capillary loss in systemic sclerosis

Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage

International consensus criteria for the diagnosis of Raynaud's phenomenon

Interstitial lung disease in systemic sclerosis: where do we stand?

Is immunosuppressive therapy the anchor treatment to achieve remission in systemic sclerosis?

Lack of efficacy of quinapril on vascular damage in limited cutaneous systemic sclerosis

Lung ultrasound for the screening of interstitial lung disease in very early systemic sclerosis

Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis

Musculoskeletal involvement in systemic sclerosis

One year in review 2016: spondyloarthritis

Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis

Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis

Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells

Progressive loss of lymphatic vessels in skin of patients with systemic sclerosis

RANK-RANKL-OPG in hemophilic arthropathy: from clinical and imaging diagnosis to histopathology

Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy

Reduced circulating levels of angiotensin-(1--7) in systemic sclerosis: a new pathway in the dysregulation of endothelial-dependent vascular tone control

Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis

Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide

Systemic sclerosis and infections

Systemic sclerosis sera affect fibrillin-1 deposition by dermal blood microvascular endothelial cells: therapeutic implications of cyclophosphamide

Systemic sclerosis: a critical digest of the recent literature

Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis

The "myth" of loss of angiogenesis in systemic sclerosis: a pivotal early pathogenetic process or just a late unavoidable event?

The antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosis

The crowded crossroad to angiogenesis in systemic sclerosis: where is the key to the problem?

The role of infections in the immunopathogensis of systemic sclerosis--evidence from serological studies

Update of EULAR recommendations for the treatment of systemic sclerosis

Upregulation of the N-formyl Peptide receptors in scleroderma fibroblasts fosters the switch to myofibroblasts

Vascular biomarkers and correlation with peripheral vasculopathy in systemic sclerosis

Vascular complications of scleroderma

Vascular injury in systemic sclerosis: angiotensin-converting enzyme insertion/deletion polymorphism

Very early versus early disease: the evolving definition of the 'many faces' of systemic sclerosis